Skip to main content
Premium Trial:

Request an Annual Quote

Certara, ChemAxon to Combine Cheminformatics Software

Premium

Certara said this week that it has signed a partnership with ChemAxon that will allow it to provide its customers with access to ChemAxon’s MarvinSketch and JChem Cartridge for Oracle through its D360 solution.

Certara’s D360 is an integrated solution for querying, analyzing, and visualization scientific data used by pharmaceutical and biotech companies to access data sources for drug discovery and development. This agreement will provide D360 customers with MarvinSketch, which is a chemical structure sketching tool, and the JChem Chemistry data cartridge.

The partnership allows “[us] to seamlessly integrate and deliver other data types, such as biologic assay or preclinical safety data, with chemistry data from ChemAxon via simple queries that any user can develop,” Jonathan Feldman, Certara’s vice president of scientific informatics, said in a statement.

The financial details of the agreement were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.